{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:18:49Z","timestamp":1768533529920,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Hypophosphatasia (HPP) and type 1 diabetes (T1D) are both associated with low bone turnover and increased fracture risk. In this review, our objectives were to (a) discuss results of our pilot study aimed to evaluate prevalence and clinical and radiological characteristics of HPP in adults with T1D and (b) to review literature on the use of electronic medical records (EMR) for HPP case findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>In our pilot study, 18 individuals had persistent low alkaline phosphatase levels (ALP) [18\/1723, 1.05%]. Among 10 participants who completed the study with potential HPP and T1D, three had a pathogenic ALPL mutation (0.16% prevalence), and six had elevated serum vitamin B6. No significant differences were found in DXA-based bone density, QCT-based bone density, or Finite element-estimated bone strength between the potential HPP group, T1D adults, and controls. We did not find any study that evaluated persistent low ALP levels or potential HPP in patients with diabetes (either type 1 or type 2 diabetes). The literature reported higher prevalence of low ALP levels when electronic medical records were searched (~\u20091\u20133%). However, prevalence of suspected HPP based on persistent low ALP levels and\/or clinical signs and symptoms was around 0.5% or lower depending on sample size, methods and geographical locations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Our study suggests that EMR-based screening for HPP is feasible and may identify previously undiagnosed cases of HPP. Prevalence of potential HPP in T1D is around 1% and genetically confirmed HPP is 0.16% which is similar to reported prevalence of HPP in selected population without diabetes. Skeletal imaging and clinical presentations are not sufficient for identifying potential HPP in individuals with T1D. Given the increased fracture risk and low bone turnover typically seen in T1D, we propose that an EMR-based screening strategy could be a more effective approach for diagnosing HPP in T1D population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11914-025-00938-x","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:44:19Z","timestamp":1759988659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypophosphatasia and Type 1 Diabetes: A Pilot Study and Review of Literature"],"prefix":"10.1007","volume":"23","author":[{"given":"Zunera","family":"Tariq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake P.","family":"Tinsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet K.","family":"Snell-Bergeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-7107","authenticated-orcid":false,"given":"Viral N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"4","key":"938_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233\u201346.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"938_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet. 2011;75(3):439\u201345.","journal-title":"Ann Hum Genet"},{"issue":"7","key":"938_CR3","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jbmr.2178","volume":"29","author":"FE McKiernan","year":"2014","unstructured":"McKiernan FE, Berg RL, Fuehrer J. Clinical and radiographic findings in adults with persistent hypophosphatasemia. J Bone Min Res. 2014;29(7):1651\u201360.","journal-title":"J Bone Min Res"},{"issue":"6","key":"938_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10495","volume":"5","author":"K Koehler","year":"2021","unstructured":"Koehler K, Atway S, Pipes J, Ing S. Diagnosis of hypophosphatasia in adults presenting with metatarsal stress fracture: proof-of-concept for a case-finding strategy. JBMR Plus. 2021;5(6):e10495.","journal-title":"JBMR Plus"},{"issue":"12","key":"938_CR5","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s00198-022-06536-2","volume":"33","author":"N Hepp","year":"2022","unstructured":"Hepp N, Frederiksen AL, Duno M, J\u00f8rgensen NR, Jensen JB. Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study. Osteoporos Int. 2022;33(12):2595\u2013605.","journal-title":"Osteoporos Int"},{"issue":"9","key":"938_CR6","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/dme.12734","volume":"32","author":"VN Shah","year":"2015","unstructured":"Shah VN, Shah CS, Snell-Bergeon JK. Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med. 2015;32(9):1134\u201342.","journal-title":"Diabet Med"},{"issue":"10","key":"938_CR7","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2337\/dc15-0783","volume":"38","author":"DR Weber","year":"2015","unstructured":"Weber DR, Haynes K, Leonard MB, Willi SM, Denburg MR. Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care. 2015;38(10):1913\u201320.","journal-title":"Diabetes Care"},{"issue":"11","key":"938_CR8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jdiacomp.2018.08.016","volume":"32","author":"R Dhaliwal","year":"2018","unstructured":"Dhaliwal R, Foster NC, Boyle C, et al. Determinants of fracture in adults with type 1 diabetes in the USA: results from the T1D exchange clinic registry. J Diabetes Complications. 2018;32(11):1006\u201311.","journal-title":"J Diabetes Complications"},{"issue":"6","key":"938_CR9","doi-asserted-by":"publisher","first-page":"e2405","DOI":"10.1210\/clinem\/dgac099","volume":"107","author":"MR Rubin","year":"2022","unstructured":"Rubin MR, de Boer IH, Backlund JC, et al. Biochemical markers of bone turnover in older adults with type 1 diabetes. J Clin Endocrinol Metab. 2022;107(6):e2405\u201316.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"938_CR10","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1210\/clinem\/dgad255","volume":"108","author":"C Meier","year":"2023","unstructured":"Meier C, Eastell R, Pierroz DD, et al. Biochemical markers of bone fragility in patients with diabetes. A narrative review by the IOF and the ECTS. J Clin Endocrinol Metab. 2023;108(10):e923\u201336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"938_CR11","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2337\/dc23-0495","volume":"46","author":"KE Karakus","year":"2023","unstructured":"Karakus KE, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN. Association between diabetes technology use and glycemic outcomes in adults with type 1 diabetes over a decade. Diabetes Care. 2023;46(9):1646\u201351.","journal-title":"Diabetes Care"},{"issue":"11","key":"938_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10831","volume":"7","author":"VN Shah","year":"2023","unstructured":"Shah VN, Qui S, Stoneback J, et al. Bone structure and turnover in postmenopausal women with long-standing type 1 diabetes. JBMR Plus. 2023;7(11):e10831.","journal-title":"JBMR Plus"},{"issue":"10","key":"938_CR13","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1210\/jc.2018-02763","volume":"104","author":"VN Shah","year":"2019","unstructured":"Shah VN, DuBose SN, Li Z, et al. Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. J Clin Endocrinol Metab. 2019;104(10):4356\u201364.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"938_CR14","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/jbmr.4130","volume":"35","author":"L Seefried","year":"2020","unstructured":"Seefried L, Dahir K, Petryk A, et al. Burden of illness in adults with hypophosphatasia: data from the global hypophosphatasia patient registry. J Bone Miner Res. 2020;35(11):2171\u20138.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"938_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12891-019-2420-8","volume":"20","author":"W H\u00f6gler","year":"2019","unstructured":"H\u00f6gler W, Langman C, Gomes da Silva H, et al. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord. 2019;20(1):80.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"938_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF00298740","volume":"56","author":"KG Faulkner","year":"1995","unstructured":"Faulkner KG, Genant HK, McClung M. Bilateral comparison of femoral bone density and hip axis length from single and fan beam DXA scans. Calcif Tissue Int. 1995;56(1):26\u201331.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"938_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF02509376","volume":"58","author":"SL Bonnick","year":"1996","unstructured":"Bonnick SL, Nichols DL, Sanborn CF, Payne SG, Moen SM, Heiss CJ. Right and left proximal femur analyses: is there a need to do both? Calcif Tissue Int. 1996;58(5):307\u201310.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"938_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0021-9290(03)00071-X","volume":"36","author":"EF Morgan","year":"2003","unstructured":"Morgan EF, Bayraktar HH, Keaveny TM. Trabecular bone modulus-density relationships depend on anatomic site. J Biomech. 2003;36(7):897\u2013904.","journal-title":"J Biomech"},{"issue":"4","key":"938_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0736-0266(01)00185-1","volume":"20","author":"DL Kopperdahl","year":"2002","unstructured":"Kopperdahl DL, Morgan EF, Keaveny TM. Quantitative computed tomography estimates of the mechanical properties of human vertebral trabecular bone. J Orthop Res. 2002;20(4):801\u20135.","journal-title":"J Orthop Res"},{"issue":"5","key":"938_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0021-9290(01)00011-2","volume":"34","author":"EF Morgan","year":"2001","unstructured":"Morgan EF, Keaveny TM. Dependence of yield strain of human trabecular bone on anatomic site. J Biomech. 2001;34(5):569\u201377.","journal-title":"J Biomech"},{"issue":"4","key":"938_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S8756-3282(03)00210-2","volume":"33","author":"RP Crawford","year":"2003","unstructured":"Crawford RP, Cann CE, Keaveny TM. Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone. 2003;33(4):744\u201350.","journal-title":"Bone"},{"issue":"8","key":"938_CR22","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00198-017-4035-y","volume":"28","author":"FE McKiernan","year":"2017","unstructured":"McKiernan FE, Dong J, Berg RL, Scotty E, Mundt P, Larson L, Rai I. Mutational and biochemical findings in adults with persistent hypophosphatasemia. Osteoporos Int. 2017;28(8):2343\u20138.","journal-title":"Osteoporos Int"},{"key":"938_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejim.2015.12.019","volume":"29","author":"L Riancho-Zarrabeitia","year":"2016","unstructured":"Riancho-Zarrabeitia L, Garc\u00eda-Unzueta M, Tenorio JA, et al. Clinical, biochemical and genetic spectrum of low alkaline phosphatase levels in adults. Eur J Intern Med. 2016;29:40\u20135.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"938_CR24","doi-asserted-by":"publisher","first-page":"e004316","DOI":"10.1136\/rmdopen-2024-004316","volume":"10","author":"G Larid","year":"2024","unstructured":"Larid G, Vix J, Preuss P, et al. Detection of hypophosphatasia in hospitalised adults in rheumatology and internal medicine departments: a multicentre study over 10 years. RMD Open. 2024;10(2):e004316.","journal-title":"RMD Open"},{"issue":"3","key":"938_CR25","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00198-015-3346-0","volume":"27","author":"E Maman","year":"2016","unstructured":"Maman E, Borderie D, Roux C, Briot K. Absence of recognition of low alkaline phosphatase level in a tertiary care hospital. Osteoporos Int. 2016;27(3):1251\u20134.","journal-title":"Osteoporos Int"},{"key":"938_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2021.101101","volume":"15","author":"N Hepp","year":"2021","unstructured":"Hepp N, Frederiksen AL, Duno M, Pr\u00e6st Holm J, Rye J\u00f8rgensen N, Beck Jensen JE. Biochemical, clinical and genetic characteristics in adults with persistent hypophosphatasaemia; data from an endocrinological outpatient clinic in Denmark. Bone Rep. 2021;15:101101.","journal-title":"Bone Rep"},{"issue":"1","key":"938_CR27","doi-asserted-by":"publisher","first-page":"9569","DOI":"10.1038\/s41598-019-46004-2","volume":"9","author":"C Garc\u00eda-Fontana","year":"2019","unstructured":"Garc\u00eda-Fontana C, Villa-Su\u00e1rez JM, And\u00fajar-Vera F, et al. Epidemiological, clinical and genetic study of hypophosphatasia in a Spanish population: identification of two novel mutations in the Alpl gene. Sci Rep. 2019;9(1):9569.","journal-title":"Sci Rep"},{"issue":"1","key":"938_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s13023-021-02084-w","volume":"16","author":"T Schmidt","year":"2021","unstructured":"Schmidt T, Schmidt C, Amling M, Kramer J, Barvencik F. Prevalence of low alkaline phosphatase activity in laboratory assessment: is hypophosphatasia an underdiagnosed disease? Orphanet J Rare Dis. 2021;16(1):452.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"938_CR29","first-page":"289","volume":"65","author":"LHR Vieira","year":"2021","unstructured":"Vieira LHR, Peixoto KC, Fl\u00f3si CL, de Farias MLF, Madeira M. Active search of adult patients with persistently low serum alkaline phosphatase levels for the diagnosis of hypophosphatasia. Arch Endocrinol Metab. 2021;65(3):289\u201394.","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"938_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s13023-022-02572-7","volume":"17","author":"J Feurstein","year":"2022","unstructured":"Feurstein J, Behanova M, Haschka J, et al. Identifying adult hypophosphatasia in the rheumatology unit. Orphanet J Rare Dis. 2022;17(1):435.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"938_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jbmr.3928","volume":"35","author":"N Alonso","year":"2020","unstructured":"Alonso N, Larraz-Prieto B, Berg K, et al. Loss-of-function mutations in the ALPL gene presenting with adult onset osteoporosis and low serum concentrations of total alkaline phosphatase. J Bone Miner Res. 2020;35(4):657\u201361.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"938_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s00774-023-01440-z","volume":"41","author":"P Calmarza","year":"2023","unstructured":"Calmarza P, Lapresta C, Mart\u00ednez Garc\u00eda M, et al. Musculoskeletal pain and muscular weakness as the main symptoms of adult hypophosphatasia in a Spanish cohort: clinical characterization and identification of a new ALPL gene variant. J Bone Miner Metab. 2023;41(5):654\u201365.","journal-title":"J Bone Miner Metab"},{"issue":"12","key":"938_CR33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.eprac.2021.07.005","volume":"27","author":"HB Quinn","year":"2021","unstructured":"Quinn HB, Busch RS, Kane MP. The occurrence and burden of hypophosphatasia in an ambulatory care endocrinology practice. Endocr Pract. 2021;27(12):1189\u201392.","journal-title":"Endocr Pract"},{"issue":"9","key":"938_CR34","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Mussawy H, Rolvien T, et al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int. 2017;28(9):2653\u201362.","journal-title":"Osteoporos Int"},{"key":"938_CR35","doi-asserted-by":"publisher","first-page":"115795","DOI":"10.1016\/j.bone.2020.115795","volume":"144","author":"R Desborough","year":"2021","unstructured":"Desborough R, Nicklin P, Gossiel F, et al. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic. Bone. 2021;144:115795.","journal-title":"Bone"},{"issue":"12","key":"938_CR36","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00198-022-06480-1","volume":"33","author":"S Sadhukhan","year":"2022","unstructured":"Sadhukhan S, Mehta P, Rajender S, Gupta SK, Chattopadhyay N. Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations. Osteoporos Int. 2022;33(12):2479\u201393.","journal-title":"Osteoporos Int"},{"issue":"6","key":"938_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00223-023-01082-3","volume":"112","author":"FN Schmidt","year":"2023","unstructured":"Schmidt FN, Schmidt C, Delsmann J, Amling M, Barvencik F, Radial HR-pQCT. Finite element analysis in HPP patients are superior in identifying susceptibility to Fracture-Associated skeletal affections compared to DXA and laboratory tests. Calcif Tissue Int. 2023;112(6):691\u2013703.","journal-title":"Calcif Tissue Int"},{"key":"938_CR38","doi-asserted-by":"publisher","first-page":"116420","DOI":"10.1016\/j.bone.2022.116420","volume":"160","author":"N Hepp","year":"2022","unstructured":"Hepp N, Folkestad L, M\u00f8lleb\u00e6k S, et al. Bone-microarchitecture and bone-strength in a sample of adults with hypophosphatasia and a matched reference population assessed by HR-pQCT and impact microindentation. Bone. 2022;160:116420.","journal-title":"Bone"},{"issue":"3","key":"938_CR39","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1210\/clinem\/dgz153","volume":"105","author":"E Halper-Stromberg","year":"2020","unstructured":"Halper-Stromberg E, Gallo T, Champakanath A, et al. Bone mineral density across the lifespan in patients with type 1 diabetes. J Clin Endocrinol Metab. 2020;105(3):746\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"938_CR40","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jdiacomp.2019.107411","volume":"33","author":"VN Shah","year":"2019","unstructured":"Shah VN, Snell-Bergeon JK. Fracture risk in type 1 diabetes: think beyond bone mineral density. J Diabetes Complications. 2019;33(11):1074\u201311.","journal-title":"J Diabetes Complications"},{"issue":"3","key":"938_CR41","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00198-023-06844-1","volume":"35","author":"AA Khan","year":"2024","unstructured":"Khan AA, Brandi ML, Rush ET, et al. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024;35(3):431\u20138.","journal-title":"Osteoporos Int"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00938-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-025-00938-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00938-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:53:27Z","timestamp":1768474407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-025-00938-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["938"],"URL":"https:\/\/doi.org\/10.1007\/s11914-025-00938-x","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VNS (corresponding author) is on Editorial Board for this Journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"VNS reports personal fees from Sanofi, grants, personal fees and non-financial support from NovoNordisk, grants and personal fees from Dexcom, grants and personal fees from Insulet, grants and personal fees from Tandem Diabetes Care, personal fees from Ascensia Diabetes Care, grants and personal fees from Sequel Med Tech, grants and personal fees from Medtronic, personal fees and non-financial support from Abbott Diabetes, personal fees from Biomea Fusion, personal fees from Roche Diabetes, personal fees from T1D Scout, grants from Enable Bioscience, from Zucara Therapeutics, outside the submitted work. VNS also serves on Editorial Board for Current Osteoporosis Reports. Other authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of Interest Disclosure"}}],"article-number":"42"}}